This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Neuromodulators
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='' size='350' side='right' scene='47/475982/Cv/1' caption='Structure of the human dopamine D3 receptor in complex with the antagonist eticlopride and maltose, [[3pbl...) |
|||
| Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' scene='47/475982/Cv/1' caption='Structure of the human dopamine D3 receptor in complex with the antagonist eticlopride and maltose, [[3pbl]]'> | <StructureSection load='' size='350' side='right' scene='47/475982/Cv/1' caption='Structure of the human dopamine D3 receptor in complex with the antagonist eticlopride and maltose, [[3pbl]]'> | ||
| - | + | A neuromodulator can be conceptualized as a [[neurotransmitter]] that is not reabsorbed by the pre-synaptic neuron or broken down into a metabolite. | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 11:54, 2 January 2022
| |||||||||||
